Skip to main content
SpringerLink
Log in

Screening for Chronic Disease

  • Chapter
  • First Online:
Chronic Illness Care

Abstract

Screening is one of the most common chronic disease care activities in primary care practice. After careful shared decision-making, properly implemented screening can identify preclinical states that have the potential for treatment with a resultant reduction in adverse health events. If improperly used, screening can potentially cause harms and lead to wasteful healthcare expenditures. Clinicians should understand the general tenets of screening and clinical recommendations for counseling patients regarding the benefits versus harms of screening. The US Preventive Services Task Force is a trusted and reliable source of screening recommendations for various diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Diagnosis and screening. Evidence-based medicine. How to practice and teach EBM. 2nd ed. New York: Harcourt; 2000. p. 261.

    Google Scholar 

  2. Wilson J, Jungner G. Principles and practice of screening for disease, WHO public health paper no. 34. Geneva: World Health Organization; 1968.

    Google Scholar 

  3. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21–35.

    Article  CAS  PubMed  Google Scholar 

  4. Wilt TJ, Harris RP, Qaseem A, High Value Care Task Force of the American College of P. Screening for cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162:718–25.

    Article  PubMed  Google Scholar 

  5. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. JNCI J Natl Cancer Inst. 2009;101:1325–9.

    Article  PubMed  Google Scholar 

  6. Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71–8.

    Article  CAS  PubMed  Google Scholar 

  7. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.

    Article  CAS  PubMed  Google Scholar 

  8. Harris R, Sawaya GF, Moyer VA, Calonge N. Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive Services Task Force. Epidemiol Rev. 2011;33:20–35.

    Article  PubMed  Google Scholar 

  9. Gates TJ. Screening for cancer: concepts and controversies. Am Fam Physician. 2014;90(9):625–31.

    PubMed  Google Scholar 

  10. Jørgensen KJ, Gøtzsche PC, Kalager M. Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis. Ann Intern Med. 2017:6–7.

    Google Scholar 

  11. Harris RP, Wilt TJ, Qaseem A, High Value Care Task Force of the American College of P. A value framework for cancer screening: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162:712–7. https://doi.org/10.7326/M14-2327.

    Article  PubMed  Google Scholar 

  12. Kapp JM, Yankaskas BC, LeFevre ML. Are mammography recommendations in women younger than 40 related to increased risk? Breast Cancer Res Treat. 2010;119:485–90.

    Article  PubMed  Google Scholar 

  13. Stout NK, Nekhlyudov L, Li L, Malin ES, Ross-Degnan D, Buist DSM, et al. Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med NIH Public Access. 2014;174:114–21.

    Article  Google Scholar 

  14. Woolf SH, Harris R. The harms of screening: new attention to an old concern. JAMA. 2012;307:565–6.

    Article  PubMed  Google Scholar 

  15. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Cornell-Price J, O’Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: metaanalysis of survival data from the United States, Sweden, United Kingdom, and Denmark. Breast Dis. 2013;24:235–7.

    Google Scholar 

  16. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D, Force USPST. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med. 2007;147:871–5.

    Article  PubMed  Google Scholar 

  17. Bhutani MS, Koduru P, Joshi V, Saxena P, Suzuki R, Irisawa A, et al. The role of endoscopic ultrasound in pancreatic cancer screening. Endosc Ultrasound. 2016;5:8–16.

    Article  PubMed  PubMed Central  Google Scholar 

  18. U.S. Preventive Services Task Force Procedures Manual. Methods and processes. U.S. Preventive Services Task Force [Internet]; 2016. [cited 2016 May 11]. Available from: http://www.uspreventiveservicestaskforce.org/Page/Name/methods-and-processes.

  19. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16:175–204.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2:35.

    Article  PubMed  PubMed Central  Google Scholar 

  21. US Preventive Services Task Force. Final recommendation statement cervical cancer: screening [Internet]. 2012 [cited 2016 Nov 6]. Available from: http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical-cancer-screening#Pod2.

  22. Grade Definitions – US Preventive Services Task Force [Internet]. [cited 2016 Oct 24]. Available from: https://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions.

  23. US Preventive Services Task Force. Methods and processes: grade definitions after July 2012 [Internet]. 2013 [cited 2016 May 11]. Available from: http://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions.

  24. Agency for Healthcare Research and Quality Electronic Preventive Services Selector [Internet]. [cited 2016 Nov 6]. Available from: http://epss.ahrq.gov/PDA/index.jsp.

  25. Abbo ED, Zhang Q, Zelder M, Huang ES. The increasing number of clinical items addressed during the time of adult primary care visits. J Gen Intern Med. 2008;23:2058–65.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635–41.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. JAMA. 2010;304:1584–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kistler CE, Zimmerman S, Ward KT, Reed D, Golin C, Lewis CL. Health of older adults in assisted living and implications for preventive care. Gerontologist. 2017;57(5):949–54. https://doi.org/10.1093/geront/gnw053.

    PubMed  Google Scholar 

  29. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.

    Article  CAS  PubMed  Google Scholar 

  30. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295:801–8.

    Article  CAS  PubMed  Google Scholar 

  31. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2011;59:1444–51.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89.

    Article  PubMed  Google Scholar 

  33. Ozanne EM, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, et al. Which risk model to use? Clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomark Prev. 2013;22:146–9.

    Article  Google Scholar 

  34. Evans A, Vinnicombe S. Overdiagnosis in breast imaging. Breast. 2017;31:270–3.

    Article  PubMed  Google Scholar 

  35. Siu AL, Force USPST. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164:279–96.

    Article  PubMed  Google Scholar 

  36. Final Recommendation Statement: Breast Cancer: Screening – US Preventive Services Task Force [Internet]. U.S. Prev. Serv. Task Force. 2016 [cited 2016 Jun 11]. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/breast-cancer-screening1#citation2.

  37. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garcia FA, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:2564–75.

    Article  CAS  PubMed  Google Scholar 

  38. Segnan N, Minozzi S, Armaroli P, Cinquini M, Bellisario C, González-Lorenzo M, et al. Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: a systematic review. Int J Cancer. 2016;139:554–73.

    Article  CAS  PubMed  Google Scholar 

  39. Nelson HD, Cantor A, Humphrey L, Fu R, Pappas M, Daeges M, et al. Screening for breast cancer: a systematic review to update the 2009 U.S. Preventive Services Task Force recommendation. Rockville: Agency for Healthcare Research and Quality; 2016.

    Google Scholar 

  40. Breast Cancer Risk Assessment Tool [Internet]. Natl. Cancer Inst. 2011 [cited 2016 Jun 11]. Available from: https://www.cancer.gov/bcrisktool/Default.aspx.

  41. Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:3975–4011.

    Article  CAS  PubMed  Google Scholar 

  42. Welti LM, Beavers DP, Caan BJ, Sangi-Haghpekar H, Vitolins MZ, Beavers KM. Weight fluctuation and cancer risk in post-menopausal women: the Women’s Health Initiative. Cancer Epidemiol Biomarkers Prev. 2017;26:779–86. cebp.0611.2016.

    Article  PubMed  Google Scholar 

  43. Schairer C, Gadalla SM, Pfeiffer RM, Moore SC, Engels EA. Diabetes, abnormal glucose, dyslipidemia, hypertension and risk of inflammatory and other breast cancer. Cancer Epidemiol Biomarkers Prev. 2017;26:862–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ Croni K. Cancer statistics review, 1975–2013 – SEER statistics [Internet]. SEER Cancer Stat Rev. 2016 [cited 2016 Nov 6]. Available from: http://seer.cancer.gov/csr/1975_2013/.

  45. Lin JS, Piper MA, Perdue LA, Rutter C, Webber EM, O’Connor E, et al. Screening for colorectal cancer: a systematic review for the U.S. Preventive Services Task Force, Evidence Synthesis No. 135. AHRQ Publ. No. 14-05203-EF-1. Rockville: Agency for Healthcare Research and Quality; 2016.

    Google Scholar 

  46. Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. In: Hewitson P, editor. Cochrane Database Syst Rev. Chichester: Wiley; 2007.

    Google Scholar 

  47. Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomark Prev. 2012;21:895–904.

    Article  Google Scholar 

  48. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening test use – United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:881–8.

    Google Scholar 

  49. Agrawal S, Bhupinderjit A, Bhutani MS, Boardman L, Nguyen C, Romero Y, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100:515–23; discussion 514.

    Article  PubMed  Google Scholar 

  50. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010;102:1012–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Lee DH, Keum N, Giovannucci EL. Colorectal cancer epidemiology in the nurses’ health study. Am J Public Health. 2016;106:1599–607.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880–91. W312.

    Article  PubMed  Google Scholar 

  53. Mayrand M-H, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:1579–88.

    Article  CAS  PubMed  Google Scholar 

  54. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288:1749–57.

    Article  PubMed  Google Scholar 

  55. ASCCP Guidelines – ASCCP [Internet]. 2016 [cited 2016 Nov 6]. Available from: http://www.asccp.org/asccp-guidelines.

  56. Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120–34.

    Article  PubMed  Google Scholar 

  57. Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;(1):CD004720.

    Google Scholar 

  58. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121:1571–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367:203–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Carlsson P, Pedersen KV, Varenhorst E. Costs and benefits of early detection of prostatic cancer. Health Policy (New York). 1990;16:241–53.

    Article  CAS  Google Scholar 

  61. Carlsson SV, Holmberg E, Moss SM, Roobol MJ, Schroder FH, Tammela TL, et al. No excess mortality after prostate biopsy: results from the European randomized study of screening for prostate cancer. BJU Int. 2011;107:1912–7.

    Article  PubMed  Google Scholar 

  62. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Labrie F, Candas B, Cusan L, Gomez JL, Belanger A, Brousseau G, et al. Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial. Prostate. 2004;59:311–8.

    Article  PubMed  Google Scholar 

  64. Kjellman A, Akre O, Norming U, Tornblom M, Gustafsson O. 15-year follow up of a population based prostate cancer screening study. J Urol. 2009;181:1615–21; discussion 1621.

    Article  PubMed  Google Scholar 

  65. Detection of Prostate Cancer: American Urological Association [Internet]. 2016 [cited 2016 Nov 6]. Available from: https://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm.

  66. Final Recommendation Statement: Prostate Cancer: Screening – US Preventive Services Task Force [Internet]. 2012 [cited 2016 Nov 6]. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening.

  67. Wolters T, Roobol MJ, Steyerberg EW, van den Bergh RCN, Bangma CH, Hugosson J, et al. The effect of study arm on prostate cancer treatment in the large screening trial ERSPC. Int J Cancer. 2010;126:2387–93. NA-NA.

    CAS  PubMed  Google Scholar 

  68. Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366:981–90.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors would like to thank Russell P. Harris, MD, MPH for his valuable contributions to this chapter.

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of North Carolina, Chapel Hill, NC, USA

    Alexander Kaysin & Margaret L. Gourlay

Authors
  1. Alexander Kaysin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margaret L. Gourlay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander Kaysin .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

    Timothy P. Daaleman

  2. Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

    Margaret R. Helton

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kaysin, A., Gourlay, M.L. (2018). Screening for Chronic Disease. In: Daaleman, T., Helton, M. (eds) Chronic Illness Care. Springer, Cham. https://doi.org/10.1007/978-3-319-71812-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71812-5_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71811-8

  • Online ISBN: 978-3-319-71812-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation